A second look at anorectal infections in cancer patients in a large cancer institute

The success of early intervention with antibiotics and surgery

T. Lehrnbecher, D. Marshall, C. Gao, S. J. Chanock

Research output: Contribution to journalArticle

Abstract

Background: Infection of anorectal region represents a significant compilication of anti-cancer therapy. Anorectal infection occurs in patients receiving aggressive chemotherapy. Untreated infection leads to substantial morbidity and in the past, mortality. Methods: 82 episodes of anorectal infection in 64 patients with malignant diseases occurring over 12 years at the National Cancer Institute (NCI) were retrospectively reviewed. Results: The overall incidence is comparable to the prior NCI experience despite a shift in patient population to a lower percentage of lymphoid/leukemic diagnoses (34% vs 77%). There were no deaths associated with anorectal infection in the 12 years reviewed compared to seven of 44 in the previous decade (p = 0.003). Antibiotic therapy alone was successful in managing 52/82 episodes, whereas surgery and antibiotics were required in 25/82. Only five episodes were treated with surgery alone compared to nearly 45% in the previous decade. There were no major surgical complications. Neutropenia was present in 43/82 episodes. 11 episodes were complicated by bacteremia, predominately with Staphylococcus non-aureus (n = 8). Wound cultures were performed in 36 episodes from 23 patients yielding 99 separate isolates. Gram-negative isolates were most common overall. Modification of antibiotic therapy with further anaerobic coverage was administered successfully in 39/77 episodes. Conclusion: This study illustrates that anorectal infections in cancer patients can be successfully managed with antibiotic therapy and local care; surgery can be withheld unless there is evidence of progressive infection or substantial fluctuance and necrosis.

Original languageEnglish (US)
Pages (from-to)272-276
Number of pages5
JournalInfection
Volume30
Issue number5
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Anti-Bacterial Agents
Infection
Neoplasms
National Cancer Institute (U.S.)
Therapeutics
Bacteremia
Neutropenia
Staphylococcus aureus
Necrosis
Morbidity
Drug Therapy
Mortality
Incidence
Wounds and Injuries
Population

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

A second look at anorectal infections in cancer patients in a large cancer institute : The success of early intervention with antibiotics and surgery. / Lehrnbecher, T.; Marshall, D.; Gao, C.; Chanock, S. J.

In: Infection, Vol. 30, No. 5, 2002, p. 272-276.

Research output: Contribution to journalArticle

@article{332c7ad9f0b9456a80d7939df6054a19,
title = "A second look at anorectal infections in cancer patients in a large cancer institute: The success of early intervention with antibiotics and surgery",
abstract = "Background: Infection of anorectal region represents a significant compilication of anti-cancer therapy. Anorectal infection occurs in patients receiving aggressive chemotherapy. Untreated infection leads to substantial morbidity and in the past, mortality. Methods: 82 episodes of anorectal infection in 64 patients with malignant diseases occurring over 12 years at the National Cancer Institute (NCI) were retrospectively reviewed. Results: The overall incidence is comparable to the prior NCI experience despite a shift in patient population to a lower percentage of lymphoid/leukemic diagnoses (34{\%} vs 77{\%}). There were no deaths associated with anorectal infection in the 12 years reviewed compared to seven of 44 in the previous decade (p = 0.003). Antibiotic therapy alone was successful in managing 52/82 episodes, whereas surgery and antibiotics were required in 25/82. Only five episodes were treated with surgery alone compared to nearly 45{\%} in the previous decade. There were no major surgical complications. Neutropenia was present in 43/82 episodes. 11 episodes were complicated by bacteremia, predominately with Staphylococcus non-aureus (n = 8). Wound cultures were performed in 36 episodes from 23 patients yielding 99 separate isolates. Gram-negative isolates were most common overall. Modification of antibiotic therapy with further anaerobic coverage was administered successfully in 39/77 episodes. Conclusion: This study illustrates that anorectal infections in cancer patients can be successfully managed with antibiotic therapy and local care; surgery can be withheld unless there is evidence of progressive infection or substantial fluctuance and necrosis.",
author = "T. Lehrnbecher and D. Marshall and C. Gao and Chanock, {S. J.}",
year = "2002",
doi = "10.1007/s15010-002-2197-8",
language = "English (US)",
volume = "30",
pages = "272--276",
journal = "Infection, Supplement",
issn = "0300-8126",
publisher = "Urban und Vogel",
number = "5",

}

TY - JOUR

T1 - A second look at anorectal infections in cancer patients in a large cancer institute

T2 - The success of early intervention with antibiotics and surgery

AU - Lehrnbecher, T.

AU - Marshall, D.

AU - Gao, C.

AU - Chanock, S. J.

PY - 2002

Y1 - 2002

N2 - Background: Infection of anorectal region represents a significant compilication of anti-cancer therapy. Anorectal infection occurs in patients receiving aggressive chemotherapy. Untreated infection leads to substantial morbidity and in the past, mortality. Methods: 82 episodes of anorectal infection in 64 patients with malignant diseases occurring over 12 years at the National Cancer Institute (NCI) were retrospectively reviewed. Results: The overall incidence is comparable to the prior NCI experience despite a shift in patient population to a lower percentage of lymphoid/leukemic diagnoses (34% vs 77%). There were no deaths associated with anorectal infection in the 12 years reviewed compared to seven of 44 in the previous decade (p = 0.003). Antibiotic therapy alone was successful in managing 52/82 episodes, whereas surgery and antibiotics were required in 25/82. Only five episodes were treated with surgery alone compared to nearly 45% in the previous decade. There were no major surgical complications. Neutropenia was present in 43/82 episodes. 11 episodes were complicated by bacteremia, predominately with Staphylococcus non-aureus (n = 8). Wound cultures were performed in 36 episodes from 23 patients yielding 99 separate isolates. Gram-negative isolates were most common overall. Modification of antibiotic therapy with further anaerobic coverage was administered successfully in 39/77 episodes. Conclusion: This study illustrates that anorectal infections in cancer patients can be successfully managed with antibiotic therapy and local care; surgery can be withheld unless there is evidence of progressive infection or substantial fluctuance and necrosis.

AB - Background: Infection of anorectal region represents a significant compilication of anti-cancer therapy. Anorectal infection occurs in patients receiving aggressive chemotherapy. Untreated infection leads to substantial morbidity and in the past, mortality. Methods: 82 episodes of anorectal infection in 64 patients with malignant diseases occurring over 12 years at the National Cancer Institute (NCI) were retrospectively reviewed. Results: The overall incidence is comparable to the prior NCI experience despite a shift in patient population to a lower percentage of lymphoid/leukemic diagnoses (34% vs 77%). There were no deaths associated with anorectal infection in the 12 years reviewed compared to seven of 44 in the previous decade (p = 0.003). Antibiotic therapy alone was successful in managing 52/82 episodes, whereas surgery and antibiotics were required in 25/82. Only five episodes were treated with surgery alone compared to nearly 45% in the previous decade. There were no major surgical complications. Neutropenia was present in 43/82 episodes. 11 episodes were complicated by bacteremia, predominately with Staphylococcus non-aureus (n = 8). Wound cultures were performed in 36 episodes from 23 patients yielding 99 separate isolates. Gram-negative isolates were most common overall. Modification of antibiotic therapy with further anaerobic coverage was administered successfully in 39/77 episodes. Conclusion: This study illustrates that anorectal infections in cancer patients can be successfully managed with antibiotic therapy and local care; surgery can be withheld unless there is evidence of progressive infection or substantial fluctuance and necrosis.

UR - http://www.scopus.com/inward/record.url?scp=0036389478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036389478&partnerID=8YFLogxK

U2 - 10.1007/s15010-002-2197-8

DO - 10.1007/s15010-002-2197-8

M3 - Article

VL - 30

SP - 272

EP - 276

JO - Infection, Supplement

JF - Infection, Supplement

SN - 0300-8126

IS - 5

ER -